NCT01697605View on ClinicalTrials.gov

A Phase I Study of Oral BGJ398 in Asian Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 19, 2012

Primary Completion Date

February 7, 2019

Study Completion Date

February 7, 2019

Conditions
Tumor With Alterations of the FGF-R
Interventions
DRUG

BGJ398

Trial Locations (8)

51000

Novartis Investigative Site, Guangzhou

510060

Novartis Investigative Site, Guangzhou

610041

Novartis Investigative Site, Chengdu

466-8560

Nagoya University Hospital, Nagoya

277-8577

National Cancer Center Hospital East (NCEE), Kashiwa

650-0017

Novartis Investigative Site, Kobe

589 8511

Novartis Investigative Site, Sayama

411-8777

Shizuoka Cancer Center, Sunto-gun

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY